Volume 10

Anti-Cancer Drugs

Volume 10

1

Induction of apoptotic cell death in human hepatocellular carcinoma SK-HEP-1 cells by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone)

Hashimoto, Yasushi, Hibasami, Hiroshige, Tamaki, Shigenori, Kamei, Akira, Ikoma, Jiro, Kaito, Masahiko, Imoto, Ichiro, Watanabe, Shozo, Nakashima, Kunio, Adachi, Yukihiko

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 304 KB

1999

2

Increasing options in cancer therapy

Georgoulias, Vasilis, Crown, John P

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 207 KB

1999

3

Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-α in patients with advanced head and neck squamous cell carcinoma

Gravis, Gwenaelle, Pech-Gourgh, Francois, Viens, Patrice, Alzieu, Claude, Camerlo, Jacques, Oziel-Taieb, Sandrine, Jausseran, Michel, Maraninchi, Dominique

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 446 KB

1999

4

Phthalimide analogs of CB 1954

Mehta, Lina K, Hobbs, Steve, Chen, Shuian, Knox, Richard J, Patrick, John

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 514 KB

1999

5

Dendrimer-platinate

Malik, Navid, Evagorou, Evagoras G, Duncan, Ruth

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 620 KB

1999

6

A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia

Hidalgo, M, Rinaldi, D, Medina, G, Griffin, T, Turner, J, Hoff, DD Von

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 219 KB

1999

7

Variable intrinsic sensitivity of human tumor cell lines to raltitrexed (Tomudex®) and folylpolyglutamate synthetase activity

Chéradame, S, Chazal, M, Fischel, J L, Formento, P, Renée, N, Milano, G

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 488 KB

1999

8

Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units

Hidalgo, Manuel, Izbicka, Elzbieta, Eckhardt, S Gail, MacDonald, John R, Cerna, Cesario, Gomez, Lionel, Rowinsky, Eric K, Weitman, Steven D, Von Hoff, Daniel D

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 627 KB

1999

9

Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration

Nuijen, B, Bouma, M, Henrar, REC, Manada, C, Bult, A, Beijnen, J H

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 633 KB

1999

10

Inhibitory effect of ND2001 on spontaneous multiple metastasis of NC 65 tumors derived from human renal cancer cells intradermally transplanted into nude mice

Nakatsugawa, Shigekazu, Okuda, Takahito, Muramoto, Hideyuki, Koyama, Kazuyuki, Ishigaki, Takeo, Tsuruoka, Tsutomu, Hosokawa, Masuo, Kobayashi, Hiroshi

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 316 KB

1999

11

Risk of transient hyperammonemic encephalopathy in cancer patients who received continuous infusion of 5-fluorouracil with the complication of dehydration and infection

Liaw, Chuang-Chi, Wang, Hung-Ming, Wang, Cheng-Hsu, Yang, Tsai-Shen, Chen, Jen-Shi, Chang, Hsien-Khun, Lin, Yung-Chang, Liaw, Shiumn-Jen, Yeh, Chau-Ting

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 498 KB

1999

12

DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2ʼ-deoxycytidine

Bovenzi, Veronica, Lê, Ngoc Loan Oanh, Côté, Sylvie, Sinnett, Daniel, Momparler, Louise F, Momparler, Richard L

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 435 KB

1999

13

Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes

Riesbeck, Kristian

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 626 KB

1999

14

Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumors

Planting, AST, Schellens, JHM, van der Burg, MEL, de Boer-Oennert, M, Winograd, B, Stoter, G, Verweij, J

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 462 KB

1999

15

In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells

Wang, Yuying, Eksborg, Staffan, Lewensohn, Rolf, Lindberg, Annika, Liliemark, Eva

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 479 KB

1999

16

Conventional dose melphalan is inactive in metastatic melanoma

Hochster, Howard, Strawderman, Myla Hunt, Harris, Jules E, Atkins, Michael B, Oken, Martin, Skeel, Roland T, Jubelirer, Steven J, Parkinson, David

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 275 KB

1999

17

Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units

Petit, Thierry, Izbicka, Elzbieta, Lawrence, Richard A, Nalin, Carlo, Weitman, Steven D, Von Hoff, Daniel D

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 488 KB

1999

18

Synthesis of [99mTc]ethyjenedicysteine-colchicine for evaluation of antiangiogenic effect

Zareneyrizi, Fereshteh, Yang, David J, Oh, Chang-Sok, Ilgan, Seyfettin, Yu, Dong-Fang, Tansey, Wayne, Liu, Chun-Wei, Kim, E Edmund, Podoloff, Donald A

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 471 KB

1999

19

The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis

Hasinoff, Brian B, Chee, Gaik-Lean, Thampatty, Padmakumari, Allan, William P, Yalowich, Jack C

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 672 KB

1999

20

Growth inhibitory effect of L-canavanine against MIA PaCa-2 pancreatic cancer cells is not due to conversion to its toxic metabolite canaline

Swaffar, Diane Shomin, Ang, Choo Yaw

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 431 KB

1999

21

Antitumor activity of KF22678, a novel thioester derivative of leinamycin

Ashizawa, Tadashi, Kawashima, Kenji, Kanda, Yutaka, Gomi, Katsushige, Okabe, Masami, Ueda, Kazumitsu, Tamaoki, Tatsuya

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 482 KB

1999

22

Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines

Gu, Wen-Zhen, Chen, Zehan, Tahir, Stephen K, Rosenberg, Saul H, Ng, Shi-Chung

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 445 KB

1999

23

Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]

Sava, G, Clerici, K, Capozzi, I, Cocchietto, M, Gagliardi, R, Alessio, E, Mestroni, G, Perbellini, A

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 717 KB

1999

24

Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay

Hidalgo, Manuel, Izbicka, Elzbieta, Cerna, Cesario, Gomez, Lionel, Rowinsky, Eric K, Weitman, Steven D, Von Hoff, Danie D

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 530 KB

1999

25

Continuous delivery of venous 5-fluorpuracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer

Focan, C, Levi, F, Kreutz, F, Focan-Henrard, D, Lobelle, J P, Adam, R, Dallemagne, B, Jehaes, C, Markiewicz, S, Weerts, J, Bismuth, H, Jasmin, C, Misset, J L

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 566 KB

1999

26

Microtubule-disrupting effects of gallium chloride in vitro

Perchellet, Elisabeth M, Ladesich, James B, Collery, Philippe, Perchellet, Jean-Pierre

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 966 KB

1999

27

Population pharmacokinetic approach to compare oral and i.v. administration of etoposide

Würthwein, Gudrun, Krümpelmann, Sebastian, Tillmann, Barbara, Real, Eva, Schulze-Westhoff, Petra, Jürgens, Herbert, Boos, Joachim

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 573 KB

1999

28

Key word index to volume 10

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 151 KB

1999

29

New horizons

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 261 KB

1999

30

Pharmacokinetics and central nervous system toxicity of declopramide (3-chloroprocainamide) in rats and mice

Hua, Jianyi, Pero, Ronald W, Kane, Robert

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 710 KB

1999

31

Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer

Possinger, K, Kaufmann, M, Coleman, R, Stuart, NSA, Helsing, M, Ohnmacht, U, Arning, M

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 504 KB

1999

32

Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg

Wils, J, van Geuns, H, Stoot, J, Bergmans, M, Boschma, F, Bron, H, Degen, J, Erdkamp, F, van Erp, J, Haest, J, Iding, R, Lallsang, F, de Pree, N, de Rooy, C, Snijders, M, Schepers, J, Vreeswijk, J, Wa

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 339 KB

1999

33

Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system

Diab, Sami G, Hilsenbeck, Susan G, Izbicka, Elzbieta, Weitman, Steven D, Von Hoff, Daniel D

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 331 KB

1999

34

A unique paclitaxel-mediated modulation of the catalytic activity of topoisomerase IIα

Dhawan, Vijender, Swaffar, Diane Shomin

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 604 KB

1999

35

Synthesis and cytotoxic activity of thiazolyl indolequinones

Moody, Christopher J, Roffey, Jonathan RA, Swann, Elizabeth, Lockyer, Stacey, Houlbrook, Susan, Stratford, Ian J

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 877 KB

1999

36

Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans

Loos, Walter J, Verweij, Jaap, Gelderblom, Hans J, de Jonge, Maja JA, Brouwer, Eric, Dallaire, Brian K, Sparreboom, Alex

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 434 KB

1999

37

Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein

Sparreboom, Alex, Planting, André ST, Jewell, Roxanne C, van der Burg, Maria EL, van der Gaast, Ate, de Bruijn, Peter, Loos, Walter J, Nooter, Kees, Chandler, LuWanda H, Paul, Elaine M, Wissel, Paul S

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 715 KB

1999

38

Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer

Hartmann, J T, Quietzsch, D, Daikeler, T, Kollmannsberger, C, Mayer, F, Kanz, L, Bokemeyer, C

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 366 KB

1999

39

Phase II study of raltitrexed (Tomudex®) in chemotherapy-pretreated patients with advanced colorectal cancer

Sato, Atsushi, Kurihara, Minoru, Horikoshi, Noboru, Aiba, Keisuke, Kikkawa, Nobuteru, Shirouzu, Kazuo, Mitachi, Yasushi, Sakata, Yuh, Wakui, Akira

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 578 KB

1999

40

Pharmacokinetic interaction between etoposide and tamoxifen in patients with hepatocellular carcinoma

Corona, Giuseppe, Aita, Paola, Sorio, Roberto, Colussi, Anna Maria, Bearz, Alessandra, Sartor, Franca, Boiocchi, Mauro, Toffoli, Giuseppe

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 347 KB

1999

41

Makaluvamines vary in ability to induce dosedependent DNA cleavage via topoisomerase II interaction

Matsumoto, Sandra S, Haughey, Heather M, Schmehl, Derek M, Venables, Debra A, Ireland, Chris M, Holden, Joseph A, Barrows, Louis R

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 510 KB

1999

42

Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma

Kollmannsberger, Christian, Brugger, Wolfram, Hartmann, Jörg T, Maurer, Franz, Böhm, Paul, Kanz, Lothar, Bokemeyer, Carsten

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 258 KB

1999

43

Effect of cyclosporin A on protein binding of teniposide in cancer patients

Toffoli, Giuseppe, Aita, Paola, Sorio, Roberto, Corona, Giuseppe, Bertola, Antonella, Colussi, Anna Maria, Robieux, Isabelle, Boiocchi, Mauro

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 567 KB

1999

44

Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole

Akiyama, Tadakazu, Shimizu, Makiko, Okabe, Masami, Tamaoki, Tatsuya, Akinaga, Shiro

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 928 KB

1999

45

Inhibition of Na+,K+-ATPase by cisplatin and its recovery by 2-mercaptoethanol in human squamous cell carcinoma cells

Sakakibara, Noriyuki, Suzuki, Kuniaki, Kaneta, Hiroyuki, Yoshimura, Yoshitaka, Deyama, Yoshiaki, Matsumoto, Akira, Fukuda, Hiroshi

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 646 KB

1999

46

Heterogeneity of chemosensitivity of metastatic cutaneous melanoma

Cree, Ian A, Neale, Michael H, Myatt, Nyree E, de Takats, Pippa G, Hall, Per, Grant, John, Kurbacher, Christian M, Reinhold, Uwe, Neuber, Karsten, MacKie, Rona M, Chana, Jagdeep, Weaver, Paul C, Khour

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 568 KB

1999

47

Medical care consumption in a phase III trial comparing irinotecan with infusional 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer after 5-FU failure

Schmitt, C, Blijham, G, Jolain, B, Rougier, P, Cutsem, E Van

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 487 KB

1999

48

Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer

Schmid, Peter, Akrivakis, Konstantin, Flath, Bernd, Grosse, Yvonne, Sezer, Orhan, Mergenthaler, Hans-Günter, Possinger, Kurt

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 497 KB

1999

49

Phase II trial of neoadjuvant chemotherapy in early-stage small cell cervical cancer

Chang, Ting-Chang, Hsueh, Suei, Lai, Chyong-Huey, Tseng, Chih-Jen, Lee, Kam-Fai, Huang, Kuan-Gen, Chou, Hung-Hsueh, Soong, Yung-Kwei

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 484 KB

1999

50

Expanding options in breast cancer

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 475 KB

1999

51

Biodistribution and scintigraphy of [111In]DTPA-adriamycin in mammary tumor-bearing rats

Higuchi, Tetsuya, Yang, David J, llgan, Seyfettin, Tansey, L Wayne, Zareneyrizi, Fereshteh, Inoue, Tomio, Endo, Keigo, Kim, E Edmund, Podoloff, Donald A

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 413 KB

1999

52

Antitumor drug delivery by tissue electroporation

Singh, Brahma N, Dwivedi, Chandradhar

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 665 KB

1999

53

Cellular pharmacology of the combination of oxaliplatin with topotecan in the IGROV-1 human ovarian cancer cell line

Goldwasser, Francois, Bozec, Laurence, Zeghari-Squalli, Nadia, Misset, Jean-Louis

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 484 KB

1999

54

In vitro antagonistic cytotoxic interactions between platinum drugs and taxanes on bone marrow progenitor cell CFU-GM

de Graaff, Michael, Maliepaard, Marc, Pluim, Dick, Floot, Ben JG, Slaper-Cortenbach, Ineke CM, Schellens, Jan HM

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 460 KB

1999

55

Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells

Choi, Sungki, Okada, Futoshi, Kobayashi, Masanobu, Habelhah, Hasem, Nakae, Dai, Konishi, Yoichi, Totsuka, Yasunori, Hosokawa, Masuo

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 634 KB

1999

56

Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patients

Goldwasser, Fran??ois, Buthaud, Xavier, Gross, Marine, Bleuzen, Pascal, Cvitkovic, Esteban, Voinea, Aline, Jasmin, Claude, Romain, Didier, Misset, Jean-Louis

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 188 KB

1999

57

Subacute encephalopathy after combination chemotherapy including moderate-dose methotrexate in a patient with gastric cancer

Genvresse, I, Dietzmann, A, Massenkeil, G, S??pth-Schwalbe, E, Possinger, K

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 146 KB

1999

58

Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats

Stehle, Gerd, Wunder, Andreas, Schrenk, Hans Herrmann, Hartung, Gernot, Heene, Dieter L, Sinn, Hannsjörg

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 513 KB

1999

59

Hydroxyurea treatment enhances metastatic cell adhesiveness

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 113 KB

1999

60

Tricyclic pyrone analogs

Perchellet, Elisabeth M, Ladesich, James B, Magill, Molly J, Chen, Yi, Hua, Duy H, Perchellet, Jean-Pierre

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 1.30 MB

1999

61

Phase II trial of 5-fluorouracil, folinic acid and recombinant α-2a-interferon in patients with advanced colorectal cancer

Ravandi, Farhad, Rytting, Michael E, Osmon, Carlos, Braud, Edward L, Roach, Ralph W, Edwards, Kimberly, Winn, Rodger, Abbruzzese, James L, Pazdur, Richard

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 438 KB

1999

62

Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine

Gross, Marine, Hiesse, Christian, Kriaa, Fayçal, Goldwasser, François

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 301 KB

1999

63

Time-schedule dependency of S 16020, a new topoisomerase II inhibitor

Soudon, J, Milano, G, Poullain, M G, Fischel, J L, Formento, P, Berlion, M, Giroux, B

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 488 KB

1999

64

KW-2149-induced pulmonary toxicity is not prevented by corticosteroids

Schrijvers, D, Catimel, G, Highley, M, Höppener, FJP, Dirix, L, Bruijn, E De, Droz, J P, Oosterom, AT Van

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 452 KB

1999

65

Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction

Pond, Christopher D, Li, Xi-Guang, Rubin, Eric H, Barrows, Louis R

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 525 KB

1999

66

Diazene JK-279

Osmak, Maja, Bordukalo, Tatjana, Jernej, Branimir, Kosmrlj, Janez, Polanc, Slovenko

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 408 KB

1999

67

Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?

Ashmore, Sally M, Thomas, David GT, Darling, John L

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 891 KB

1999

68

Synthesis and cytotoxic activity of N-(2-chloroethyl)-N-nitroureas and N-(2-chloroethyl)-N-nitrocarbamates

Botyánszki, János, Bódi, József, Stratford, Ian J, Süli-Vargha, Helga

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 356 KB

1999

69

Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models

Bandak, Suzan, Goren, Dorit, Horowitz, Aviva, Tzemach, Dina, Gabizon, Alberto

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 602 KB

1999

70

Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies

Armand, Jean-Pierre, Cunningham, David, van Cutsem, Eric, Misset, Jean-Louis, Kohne, Claus-Henning

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 614 KB

1999

71

New options in the treatment of non-small cell lung cancer

Fossella, Frank, Rigas, James R, Belani, Chandra P

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 307 KB

1999

72

Metabolic studies of [18F-?? -methyl]tyrosine in mice bearing colorectal carcinoma LS-180

Tomiyoshi, Katsumi, Inoue, Tomio, Higuchi, Tetsuya, Ahmed, Kkaill, Sarwar, Muhammad, Alyafei, Saleh, Zhang, Hong, Matsubara, Kunio, Endo, Keigo, Yang, David

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 485 KB

1999

73

Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin

Mathijssen, Ron HJ, van Alphen, Robbert J, de Jonge, Maja JA, Verweij, Jaap, de Bruijn, Peter, Loos, Walter J, Nooter, Kees, Vernillet, Laurent, Stoter, Gerrit, Sparreboom, Alex

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 578 KB

1999

74

Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion

van Gljn, Roel, ten Bokkel Huinink, Wim W, Rodenhuis, Sjoerd, Vermorken, Jan B, van Tellingen, Olaf, Rosing, Hilde, van Warmerdam, Laurence JC, Beijnen, Jos H

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 499 KB

1999

75

Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide

Ferrari, S, Zolezzi, C, Cesari, M, Fasano, M C, Lamanna, G, Bacci, G

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 516 KB

1999

76

Impressive remission in a patient with locally advanced malignant pleural mesothelioma treated with gemcitabine

Weinmann, M, Brandes, A, ClaBen, J, Schott, U, Bamberg, M

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 404 KB

1999

77

Novel artificial endonucleases inhibit base excision repair and potentiate the cytotoxicity of DNA-damaging agents on L1210 cells

Barret, J-M, Étiévant, C, Fahy, J, Lhomme, J, Hill, B T

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 761 KB

1999

78

Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors

Soda, Hiroshi, Raymond, Eric, Sharma, Sunil, Lawrence, Richard, Cerna, Cesarlo, Gomez, Lionel, Schaub, Robert, Von Hoff, Daniel D, Izbicka, Elzbieta

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 377 KB

1999

79

Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines

Pályi, István, Kremmer, Tibor, Kálnay, Adrienn, Turi, Gizella, Mihalik, Rudolf, Bencsik, Katalin, Boldizsár, Mariann

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 607 KB

1999

80

Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines

Fujita, Manabu, Tsuchida, Tetsuo, Higashino, Kazuya

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 551 KB

1999

81

Role of red blood cells in pharmacokinetics of chemotherapeutic agents

Schrijvers, Dirk, Bruyn, Ernst De, Van Oosterom, Allan T, Vermorken, Jan B

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 585 KB

1999

82

Intracellular localization of 6-and 7-substituted 2-[2ʼ-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-diones (azonafides) is not the limiting factor for their cytotoxicity

Mayr, Craig A, Sami, Salah M, Remers, William A, Dorr, Robert T

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 536 KB

1999

83

Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide

Sankar, A, Thomas, DGT, Darling, J L

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 507 KB

1999

84

Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation

ElAttar, Tawfik MA, Virji, Adi S

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 461 KB

1999

85

First international conference on new molecular targets for anticancer therapy, Naples, 22–23 June 1998

Budillon, Alfredo, Caponigro, Francesco

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 745 KB

1999

86

A phase II study employing combination regimens containing KRN8602 in drug-resistant acute myeloid leukemia and acute lymphoblastic leukemia

Kishimoto, Y, Sampi, K, Kuraishi, Y, Takemoto, Y, Okabe, K, Tamura, K, Mizoguchi, H, Salto, H, Masaoka, T, Ogawa, M

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 478 KB

1999

87

An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer

Groener, MGH, van Ineveld, BM, van Hout, BA, Rutten, FFH

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 440 KB

1999

88

Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome

Tanaka, Masatsugu, Kanamori, Heiwa, Yamaji, Satoshi, Mishima, Aki, Fujita, Hiroyuki, Fujisawa, Shin, Murata, Takashi, Koharazawa, Hideyuki, Matsuzaki, Michio, Mohri, Hiroshi

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 183 KB

1999

89

Modulation of 9-nitrocamptothecin-induced apoptosis by hyperthermia in human leukemia HL-60 cells

Pantazis, Panayotis, Chatterjee, Devasis, Han, Zhiyong, Wyche, James

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 429 KB

1999

90

Which 5-fluorouracil regimen? — the great debate

Vincent, Mark, Labianca, Roberto, Harper, Peter

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 1.22 MB

1999

91

Weekly 24-h infusion of high-dose 5-flurouracil and leucovorin in patients with advanced gastric cancer

Chen, Jen-Shi, Liu, Hsueh-Erh, Wang, Cheng-Hsu, Yang, Tsai-Shen, Wang, Hung-Ming, Liau, Chi-Ting, Chang, Wen-Cheng, Lin, Yung-Chang

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 373 KB

1999

92

A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer

Verschraegen, Claire F, Gupta, Elora, Loyer, Evelyne, Kavanagh, John J, Kudelka, Andrzej P, Freedman, Ralph S, Edwards, Creighton L, Harris, Nick, Steger, Melissa, Steltz, Veronica, Giovanella, Beppin

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 709 KB

1999

93

Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea

Ilc, Karine, Ferrero, Jean-Marc, Fischel, Jean-Louis, Formento, Patricia, Bryce, Richard, Etienne, Marie-Christine, Milano, Gerard

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 320 KB

1999

94

Cisplatin combined with tiopronin or sodium thiosulfate

Viale, Maurizio, Zhang, Jin-Gang, Pastrone, Maria, Mariggiò, Maria A, Esposito, Mauro, Lindup, W Edward

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 676 KB

1999

95

ATP-based tumor chemosensitivity testing

Cree, Ian A, Kurbacher, Christian M

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 365 KB

1999

96

Cisplatin-resistant derivatives of murine L1210 leukemia cells are not susceptible to growth-inhibiting and apoptosis-inducing actions of transforming growth factor-β1

Stoika, R S, Yakymovych, MYa, Yakymovych, I A, Chekhun, V F

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 449 KB

1999

97

A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 417 KB

1999

98

Prolonged infusion of gemcitabine in stage IV breast cancer

Akrivakis, Konstantin, Schmid, Peter, Flath, Bernd, Schweigert, Markus, Sezer, Orhan, Mergenthaler, Hans-Günther, Possinger, Kurt

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 468 KB

1999

99

Vinflunine, a new vinca alkaloid

Jean-Decoster, Catherine, Brichese, Laetitia, Barret, Jean-Marc, Tollon, Yvette, Kruczynski, Anna, Hill, Bridget T, Wright, Michel

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 542 KB

1999

100

Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin

Dempke, Wolfram, Voigt, Wieland, Grothey, Axel, Schmoll, Hans-Joachim

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 356 KB

1999

101

Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase IIα and IIβ isoforms

van Hille, B, Perrin, D, Hill, B T

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 750 KB

1999

102

Modulation of 5-fluorpuracil by 5-ethyl-2'-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activities

Katona, Csilla, Tímár, Ferenc, Jeney, András, Fischel, Jean L, Milano, Gerard, Pandi, Erzsébet, Kralovánszky, Judit

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 558 KB

1999

103

Apoptosis induction and cell cycle perturbation in human hepatoma Hep G2 cells by 10-hydroxycamptothecin

Zhang, Xiong-Wen, and Bin Xu, Chen Qing

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 462 KB

1999

104

Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines

Hadfield, John A, Pavlidis, Vasilios H, Perry, Philip J, McGown, Alan T

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 266 KB

1999

105

Comparison of DX-8951f and topotecan effects on tumor colony formation from freshly explanted adult and pediatric human tumor cells

Lawrence, Richard A, Izbicka, Elzbieta, De Jager, Robert L, Tohgo, Akiko, Clark, Gary M, Weitman, Steven D, Rowinsky, Eric K, Von Hoff, Daniel D

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 549 KB

1999

106

FCE 24517-resistant MCF-7 human breast cancer cell line

Salvatore, Carmela, Bigioni, Mario, lafrate, Elisabetta Maria, Cianfriglia, Maurizio, Manzini, Stefano

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 453 KB

1999

107

Comparative cardiotoxicity of idarubicin and doxorubicin using the isolated perfused rat heart model

Platel, Denis, Pouna, Paul, Bonoron-Adèle, Simone, Robert, Jacques

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 369 KB

1999

108

Variable expression of the folylpolyglutamate synthetase gene at the level of mRNA transcription in human leukemia cell lines sensitive, or made resistant, to various antifolate drugs

Takemura, Yuzuru, Kobayashi, Hiroyuki, Miyachi, Hayato

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 532 KB

1999

109

Results of an independent oncology review board of pivotal clinical trials of gemcitabine in non-small cell lung cancer

Gwyther, Stephen J, Aapro, Matti S, Hatty, Sarah R, Postmus, Pieter E, Smith, Ian E

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 454 KB

1999

110

Phase I trial of gemcitabine (Gemzar®), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer

Oettle, Helmut, Pelzer, Uwe, Mochmuth, Kathrin, Diebold, Thomas, Langrehr, Jan, Schmidt, Christian A, Arning, Michael, Vogl, Thomas J, Neuhaus, Peter, Huhn, Dieter, Riess, Hanno

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 413 KB

1999

111

Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors

Hara, Isao, Yamada, Yuji, Miyake, Hideaki, Nomi, Masashi, Hara, Shoji, Yamanaka, Kazuki, Takechi, Yoshizumi, Oka, Yasuhiko, Nakamura, Ichiro, Gotoh, Akinobu, Gohji, Kazuo, Arakawa, Soichi, Kamidono, S

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 506 KB

1999

112

Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma

Bedikian, Agop Y, Legha, Sewa S, Eton, Omar, Buzaid, Antonio C, Papadopoulos, Nicholas, Plager, Carl, Mclntyre, Susan, Viallet, Jean

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 348 KB

1999

113

Triptycenes

Perchellet, Elisabeth M, Magill, Molly J, Huang, Xiaodong, Brantis, Cyrille E, Hua, Duy H, Perchellet, Jean-Pierre

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 1.39 MB

1999

114

Albumin-based drug carriers

Stehle, Gerd, Wunder, Andreas, Schrenk, Hans Herrmann, Hartung, Gernot, Heene, Dieter L, Sinn, Hannsjörg

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 491 KB

1999

115

Which is the optimal antiandrogen for use in combined androgen blockade of advanced prostate cancer? The transition from a first-to second-generation antiandrogen

Sarosdy, Michael F

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 428 KB

1999

116

In vitro chemosensitivity testing of hematological cancers

Wang, Yongchun, Ashkenazi, Yaccov J, Bachrach, Uriel

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 453 KB

1999

117

Induction of apoptosis by gallic acid in lung cancer cells

Ohno, Yasushi, Fukuda, Kazunori, Takemura, Genzou, Toyota, Miki, Watanabe, Motohiro, Yasuda, Norio, Xinbin, Qiu, Maruyama, Rumi, Akao, Seigou, Gotou, Kouji, Fujiwara, Takako, Fujiwara, Hisayoshi

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 502 KB

1999

118

Phase II study of raltitrexed (‘Tomudex’) for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens

Blay, J-Y., Judson, I., Rodenhuis, S., Hermans, C., Smith, M., van Glabbeke, M., Verweij, J.

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 297 KB

1999

119

Author index to volume 10

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 520 KB

1999

120

Irinotecan in cancers of the lung and cervix

Sandier, Alan, van Oosterom, Allan T

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 388 KB

1999

121

Progress in the treatment of ovarian cancer

Kaye, Stanley B

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 325 KB

1999

122

The chemotherapy of head and neck cancer

de Mulder, Pieter HM

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 291 KB

1999

123

List of contributors

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 15 KB

1999

124

Enhancement of cytotoxicity by abilization

Gehl, J, Skovsgaard, T, Mir, Lluis M

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 23 KB

1999

125

Patients who are receiving concomitant medications should not systematically be excluded from phase I studies

Genre, Dominique, Viens, Patrice, Von Hoff, Daniel D, Clark, Gary M

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 539 KB

1999

126

Synergism of energy starvation and dextran-conjugated doxorubicin in the killing of multidrug-resistant KB carcinoma cells

Lam, Wing, Chan, Hingleung, Yang, Mengsu, Cheng, Shukhan, Fong, Wangfun

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 586 KB

1999

127

Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures

Padrón, José M, van Moorsel, Catharina JA, Bergman, Andries M, Smitskamp-Wilms, Evelien, van der Wilt, Clasina L, Peters, Godefridus J

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 564 KB

1999

128

The cost—effectiveness of paclitaxel (Taxol)+ cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer

Annemans, Lieven, Giaccone, Giuseppe, Vergnenègre, Alain

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 731 KB

1999

129

Phase I and pharmacologic study of the arotinoid Ro 40–8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer

van Zuylen, Lia, Schellens, Jan HM, Goey, Swan H, Pronk, Linda C, de Boer-Dennert, Maureen M, Loos, Walter J, Ma, Jianguo, Stoter, Gerrit, Verweij, Jaap

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 609 KB

1999

130

Phase I trial of intoplicine (RP 60475) administered as a 72 h infusion every 3 weeks in patients with solid tumors

Newman, Robert A, Kim, Jeri, Newman, Beverly M, Bruno, Rene, Bayssas, Martine, Klink-Alakl, May, Pazdur, Richard

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 359 KB

1999

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски